Computerized Physician Order Entry Systems Market is Forecasted to Reach US$ 3.64 Billion by 2034 | Fact.MR Report
Need to Reduce Medication Errors, Streamline Workflows, and Improve Patient Safety Driving Computerized Physician Order Entry System Market Growth.
Rockville, MD, Sept. 02, 2024 (GLOBE NEWSWIRE) — As per a new research report published by Fact.MR, the
Regional Analysis:
The United States government has enacted programs such as the Meaningful Use program and the HITECH Act to encourage healthcare practitioners to use CPOE and electronic health records (EHRs). The United States has advanced IT infrastructure and a thriving IT sector, which has enabled the creation and execution of sophisticated CPOE systems. The need for CPOE systems is being driven by the popular trend of digitizing healthcare operations across the country.
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the computerized physician order entry system market for 2019 to 2023 and forecast statistics for 2024 to 2034.
The study divulges essential insights into the market based on delivery mode (web-based CPOE, on-premise CPOE, cloud-based CPOE), component (software, hardware, services), and end user (hospitals, pharmacies, laboratories), across seven major regions of the world (North America, Western Europe, Eastern Europe, East Asia, Latin America, South Asia & Pacific, and MEA).
Check out More Related Studies Published by Fact.MR Research:
Healthcare Automation Market: accounts for a valuation of US$ 38.6 billion in 2023 and is expected to surge ahead at 9.3% CAGR over the next ten years to reach a size of US$ 94 billion by the end of 2033.
OTC Pediatric Healthcare Market: is valued at US$ 11 billion in 2023 and is predicted to reach US$ 18 billion by 2033-end. Fact.MR has forecasted the market to expand at a CAGR of 5% from 2023 to 2033.
Over the Counter (OTC) Analgesics Market: was valued at around US$ 25 Bn in 2020, and is expected to accelerate at a CAGR of 5% through 2031.
Arthritis Therapeutics Market: is estimated to grow 1.5X during the forecast period (2020-2027).
Cox 2 inhibitor market: is expected to grow at a CAGR of 9.9% during the forecast period.
About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.
With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay competitive.
Follow Us: LinkedIn | Twitter | Blog
CONTACT: Contact: 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Tel: +1 (628) 251-1583 Sales Team: [email protected]
